Location History:
- Naruto, JP (2011)
- Osaka, JP (2015)
Company Filing History:
2 out of 846 
1 out of 167 Years Active: 2011-2015
Title: Minoru Kashimoto: Innovator in Pharmaceutical Science
Introduction
Minoru Kashimoto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for allergic diseases. His work has led to the creation of two patents that showcase his expertise and dedication to improving healthcare.
Latest Patents
Kashimoto's latest patents include a low-molecular polysulfated hyaluronic acid derivative and a method for stabilizing pharmaceutical preparations. The low-molecular-weight polysulfated hyaluronic acid derivative is designed for the treatment of various allergic diseases, including pollinosis, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, and asthma. This innovative agent is represented by specific general formulas, where 'n' can range from 0 to 15, and 'R' can represent a hydrogen atom or an SOH group. The second patent focuses on a method for stabilizing solid pharmaceutical preparations containing a pharmacological substance and sodium lauryl sulfate. This method enhances the performance of the preparation, ensuring high storage stability and preventing changes in properties such as the dissolution rate of the pharmacological substance.
Career Highlights
Throughout his career, Minoru Kashimoto has worked with prominent companies in the pharmaceutical industry. He has been associated with Otsuka Pharmaceutical Company, Limited, and Otsuka Chemical Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kashimoto has worked alongside notable colleagues, including Kazuaki Kakehi and Hiroaki Asai. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Minoru Kashimoto's contributions to pharmaceutical science through his patents and collaborations highlight his commitment to addressing allergic diseases. His innovative approaches continue to influence the field and improve patient outcomes.